Ensysce Biosciences Announces IRB Approval for Pivotal MPAR Study

Posted on August 27, 2024 by Vaseline

Next Clinical Trial of Breakthrough FDA Therapy PF614-MPAR Supported by $14 Million Federal Government Grant SAN DIEGO, CA …

Posted in bookmarks

Previous: World Club Dome by DJ Felix Jaehn: Auftritt in Frankfurt abgesagt

Next: Should You Buy Apple Stock Before September 9? Here’s What the Evidence Suggests | 27.08.24

bookmarks

British Columbia man convicted of injuring woman’s face with gun barrel

Vaseline
August 29, 2024
0

A man has been sentenced to four years in prison for holding a gun to a woman’s face, leaving a scar, during an attempted robbery […]

bookmarks

TRYX offers an exclusive partnership with the Pro Gamers Group for the EU market

Vaseline
October 21, 2024
0

SHANGHAI, Oct. 21, 2024 (GLOBE NEWSWIRE) — There are many people who can provide TRYX with a strategic partner with Pro Gamers Group, which is […]

bookmarks

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Investors in Ardelyx, Inc. to Retain Counsel in Securities Class Action Before Key Deadline – ARDX

Vaseline
September 4, 2024
0

New York, New York–(Newsfile Corp. – September 4, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Ardelyx, Inc. […]

Related Posts

British Columbia man convicted of injuring woman’s face with gun barrel

TRYX offers an exclusive partnership with the Pro Gamers Group for the EU market

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Investors in Ardelyx, Inc. to Retain Counsel in Securities Class Action Before Key Deadline – ARDX